You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 22, 2025

Drug Price Trends for NDC 00093-5246


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00093-5246

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 00093-5246

Understanding NDC Numbers

Before diving into the market analysis and price projections, it's essential to understand the significance of the National Drug Code (NDC) number. The NDC number, in this case, 00093-5246, is a unique identifier that helps in tracking, inventory management, and ensuring the correct medication reaches the patient. It consists of three segments: the labeler code, the product code, and the package code[1].

Drug Identification

To analyze the market and price projections for the drug with NDC 00093-5246, we first need to identify the drug. However, the provided sources do not specify the drug associated with this NDC number. Typically, this information can be found in drug databases or through pharmaceutical company resources.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is experiencing several key trends that can influence the market analysis and price projections of any drug.

Specialty Pharmaceuticals

Specialty pharmaceuticals, which include drugs for complex or chronic conditions, are driving a significant portion of the market growth. According to Vizient, specialty pharmaceuticals are expected to see a price increase of 4.18% in 2024, driven by the increasing utilization of weight loss drugs and the expansion of gene therapies[2].

Biosimilars

Biosimilars are another crucial segment, expected to grow in market share. While they are anticipated to increase in price by only 0.55%, their market share is expected to rise as pharmacy benefit managers finalize their formulary strategies. This could impact the pricing and market dynamics of branded drugs[2].

Generic Drugs

The generic drug industry is expected to face mid-single-digit percent annual price erosion but is anticipated to return to modest revenue growth. This trend could affect the pricing strategy of drugs that are nearing patent expiration or those that have generic alternatives[3].

Price Projections

Given the lack of specific information about the drug associated with NDC 00093-5246, we can only make general projections based on industry trends.

Impact of Specialty and Biosimilar Drugs

If the drug is a specialty pharmaceutical, it might see a price increase similar to the projected 4.18% for specialty drugs. However, if it is a biosimilar or has biosimilar competitors, the price increase might be more modest, around 0.55%[2].

Generic Competition

If the drug has generic alternatives or is nearing patent expiration, it could face significant price erosion. For example, drugs like Tarceva and Alimta, which are facing patent expiration, are expected to see substantial declines in sales as generic versions become available[4].

Regulatory and Compliance Factors

Regulatory compliance and FDA inspections can also impact pricing. Pharmaceutical companies must adhere to FDA regulations, and non-compliance can result in penalties, recalls, and other legal consequences. This could affect the pricing strategy as companies may need to absorb these costs[1].

Data-Driven Insights

Analyzing NDC data can provide valuable insights into market trends, patient preferences, and prescribing patterns. This data can be used to develop targeted marketing campaigns and adjust pricing strategies accordingly[1].

Example: Non-Small Cell Lung Cancer (NSCLC) Market

While not directly related to the specific NDC, the NSCLC market provides a relevant example. Drugs like Tagrisso, Keytruda, and Opdivo are projected to achieve blockbuster status, driven by their uptake in first-line and second-line treatments. However, the entry of biosimilars and generics will impact their pricing and market share[4].

Key Takeaways

  • NDC Numbers: Critical for tracking, inventory management, and patient care.
  • Market Trends: Specialty pharmaceuticals are driving growth, while biosimilars and generics impact pricing.
  • Price Projections: Dependent on the drug's category (specialty, biosimilar, generic) and regulatory compliance.
  • Data-Driven Insights: Essential for developing marketing strategies and adjusting pricing.

FAQs

  1. What is the significance of NDC numbers in the pharmaceutical industry?

    • NDC numbers provide a standardized way to identify and track medications, ensuring accurate inventory management, preventing medication errors, and aiding in regulatory compliance[1].
  2. How do specialty pharmaceuticals impact the market?

    • Specialty pharmaceuticals drive significant market growth and are expected to see a price increase of 4.18% in 2024, driven by increasing utilization and new approvals[2].
  3. What is the role of biosimilars in the pharmaceutical market?

    • Biosimilars are expected to grow in market share, with a modest price increase of 0.55%, and will gain market share as formulary strategies are finalized[2].
  4. How does generic competition affect drug pricing?

    • Generic competition leads to mid-single-digit percent annual price erosion, significantly impacting the pricing and revenue of branded drugs nearing patent expiration[3].
  5. Why is regulatory compliance important for pharmaceutical companies?

    • Regulatory compliance is crucial to avoid penalties, recalls, and other legal consequences, and to maintain high quality and safety standards as required by the FDA[1].

Sources

  1. Quality Smart Solutions - Why NDC Numbers are vital for pharmaceutical companies?
  2. Vizient, Inc. - Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
  3. S&P Global Ratings - Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures
  4. Drug Development - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.